The American Diabetes Association states that prediabetes is “a serious medical condition that can be treated”.
The risk of developing type 2 diabetes can be reduced with early intervention.
Early intervention to reduce the risk of developing diabetes is resource-saving and cost-effective in the long term.
Pharmacotherapy reduces the risk of developing diabetes (to a similar extent of lifestyle modification).
Pharmacotherapy is a cost-effective intervention in prediabetes.